Unit
Division of Infectious Diseases, Infection Prevention and Travel Medicine
INFEKT · Dept. I
Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections
Albrich W, Reutlinger B, Huber A, Sigrist T, Schuetz P, Conca A, Schild U, Regez K, Bossart R, Dusemund F, Rüegger K, Müller B. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly 2011; 141:w13237.
Jul 30, 2011Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections
Jul 30, 2011Swiss Med Wkly 2011; 141:w13237
Albrich Werner, Reutlinger B, Huber A, Sigrist T, Schuetz P, Conca A, Schild U, Regez K, Bossart R, Dusemund Frank, Rüegger K, Müller B
Group B streptococcus in prosthetic hip and knee joint-associated infections
Sendi P, Zimmerli W, Widerström m, Svensson D, Boggian K, Achermann Y, Trampuz A, Uçkay I, Christensson B, GBS PJI study group. Group B streptococcus in prosthetic hip and knee joint-associated infections. J Hosp Infect 2011; 79:64-9.
Jul 20, 2011Group B streptococcus in prosthetic hip and knee joint-associated infections
Jul 20, 2011J Hosp Infect 2011; 79:64-9
Sendi P, Zimmerli W, Widerström m, Svensson D, Boggian Katia, Achermann Y, Trampuz A, Uçkay I, Christensson B, GBS PJI study group
Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis
Mathis S, Arribas J, Meynard J, Cahn P, Vernazza P, Nelson M, Negredo E, Schechter M, Pulido F, Khanlari B, Bucher H. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. PloS one 2011; 6:e22003.
Jul 19, 2011Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis
Jul 19, 2011PloS one 2011; 6:e22003
Mathis Sandra, Arribas Jose, Meynard Jean-Luc, Cahn Pedro, Vernazza Pietro, Nelson Mark, Negredo Eugenia, Schechter Mauro, Pulido Federico, Khanlari Bettina, Bucher Heiner C
MRSA admission screening in a low prevalence setting - much ado about nothing?
Witteck A, Rettenmund G, Schlegel M. MRSA admission screening in a low prevalence setting - much ado about nothing?. Swiss Med Wkly 2011; 141:w13217.
Jul 7, 2011MRSA admission screening in a low prevalence setting - much ado about nothing?
Jul 7, 2011Swiss Med Wkly 2011; 141:w13217
Witteck Andrea, Rettenmund G, Schlegel Matthias
Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal
Tanner-Steinmann B, Boggian K. Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal. Case Report Med 2011; 2011:482815.
Jun 27, 2011Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal
Jun 27, 2011Case Report Med 2011; 2011:482815
Tanner-Steinmann Beate, Boggian Katia
Ageing with HIV: medication use and risk for potential drug-drug interactions
Marzolini C, Elzi L, Battegay M, Khoo S, Bernasconi E, Vernazza P, Calmy A, Cavassini M, Furrer H, Weber R, Back D, Swiss HIV Cohort Study Members. Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother 2011; 66:2107-11.
Jun 16, 2011Ageing with HIV: medication use and risk for potential drug-drug interactions
Jun 16, 2011J Antimicrob Chemother 2011; 66:2107-11
Marzolini Catia, Elzi Luigia, Battegay Manuel, Khoo Saye, Bernasconi Enos, Vernazza Pietro, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Weber Rainer, Back David, Swiss HIV Cohort Study Members
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
Kenfak-Foguena A, Cavassini M, Izpopet J, Abravanel F, Moradpour D, Jost J, Gurter-De La Fuente V, Elzi L, Evison J, Kaiser L, Kovari H, Darling K, Witteck A, Bürgisser P, Schöni-Affolter F, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland. Emerging Infect Dis 2011; 17:1074-8.
Jun 1, 2011Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
Jun 1, 2011Emerging Infect Dis 2011; 17:1074-8
Kenfak-Foguena Alain, Cavassini Matthais, Izpopet Jacques, Abravanel Florence, Moradpour Darius, Jost Josef, Gurter-De La Fuente Vanina, Elzi Luigia, Evison John-Marc, Kaiser Laurent, Kovari Helen, Darling Katharine E A, Witteck Andrea, Bürgisser Phillippe, Schöni-Affolter Franziska, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland
Management of hepatitis C virus (HCV) infection in drug substitution programs
Witteck A, Schmid P, Hensel-Koch K, Thurnheer M, Bruggmann P, Vernazza P. Management of hepatitis C virus (HCV) infection in drug substitution programs. Swiss Med Wkly 2011; 141:w13193.
May 27, 2011Management of hepatitis C virus (HCV) infection in drug substitution programs
May 27, 2011Swiss Med Wkly 2011; 141:w13193
Witteck Andrea, Schmid Patrick, Hensel-Koch K, Thurnheer M C, Bruggmann P, Vernazza Pietro
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
Rotger M, Miró J, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Günthard H, de Bakker P, Douek D, Silvestri G, Martinez-Picado J, Hirschel B, Fellay J, Erkizia I, Dalmau J, Rauch A, McLaren P, Bosinger S, Martinez R, Sandler N, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Telenti A. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 2011; 121:2391-400.
May 9, 2011Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
May 9, 2011J Clin Invest 2011; 121:2391-400
Rotger Margalida, Miró Jose M, Palou Eduard, Hoffmann Matthias, Massanella Marta, Blanco Julià, Woods Matthew, Günthard Huldrych F, de Bakker Paul, Douek Daniel C, Silvestri Guido, Martinez-Picado Javier, Hirschel Bernard, Fellay Jacques, Erkizia Itziar, Dalmau Judith, Rauch Andri, McLaren Paul, Bosinger Steven E, Martinez Raquel, Sandler Netanya G, Roque Annelys, Liebner Julia, Battegay Manuel, Bernasconi Enos, Descombes Patrick, Telenti Amalio
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
Albrich W, Mueller B, Reutlinger B, Buergi U, Irani S, Bregenzer T, Zimmerli W, Christ-Crain M, Rüegger K, Dusemund F, Schuetz P. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011; 11:112.
May 3, 2011Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
May 3, 2011BMC Infect Dis 2011; 11:112
Albrich Werner, Mueller Beat, Reutlinger Barbara, Buergi Ulrich, Irani Sarosh, Bregenzer Thomas, Zimmerli Werner, Christ-Crain Mirjam, Rüegger Kristina, Dusemund Frank, Schuetz Philipp
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Hirschel B, Garzoni C, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Swiss HIV Cohort Study (SHCS). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2011; 57:24-31.
May 1, 2011Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
May 1, 2011J Acquir Immune Defic Syndr 2011; 57:24-31
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Hirschel Bernard, Garzoni Christian, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Swiss HIV Cohort Study (SHCS)
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
di Iulio J, Rauch A, Telenti A, Klenerman P, Barnes E, Hirschel B, Schmid P, Bernasconi E, Battegay M, Günthard H, Furrer H, Pulit S, Martinez R, Fellay J, Rotger M, Kelleher D, Fitzmaurice K, Ciuffi A, Swiss HIV Cohort Study. Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology 2011; 53:1446-54.
May 1, 2011Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
May 1, 2011Hepatology 2011; 53:1446-54
di Iulio Julia, Rauch Andri, Telenti Amalio, Klenerman Paul, Barnes Eleanor, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Furrer Hansjakob, Pulit Sara, Martinez Raquel, Fellay Jacques, Rotger Margalida, Kelleher Dermot, Fitzmaurice Karen, Ciuffi Angela, Swiss HIV Cohort Study
Infectious Disease Burden after Solid Organ Transplantation (SOT) in the Swiss Transplant Cohort Study (STCS)
Müller N, Meylan P, Garzoni C, Hirsch H, Boggian K, Nadal D, Saccilotto R, Koller M, Van Delden C (2011). Infectious Disease Burden after Solid Organ Transplantation (SOT) in the Swiss Transplant Cohort Study (STCS).
Apr 30, 2011Infectious Disease Burden after Solid Organ Transplantation (SOT) in the Swiss Transplant Cohort Study (STCS)
Apr 30, 2011American Transplant Congress ATC 2011
Müller Nicolas J., Meylan Pascal, Garzoni Christian, Hirsch Hans H., Boggian Katia, Nadal David, Saccilotto R, Koller M, Van Delden Christian
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Haas A, Oxenius A, Günthard H, Macpherson A, Patuto N, Vernazza P, Hirschel B, Battegay M, Thurnheer M, Weber R, Bossart W, Ledergerber B, Rusert P, Slack E, Graw F, Zimmermann K, Swiss HIV Cohort Study. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011; 60:1506-19.
Apr 21, 2011Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Apr 21, 2011Gut 2011; 60:1506-19
Haas Anna, Oxenius Annette, Günthard Huldrych F, Macpherson Andrew J, Patuto Nicola, Vernazza Pietro, Hirschel Bernard, Battegay Manuel, Thurnheer Maria C, Weber Rainer, Bossart Walter, Ledergerber Bruno, Rusert Peter, Slack Emma, Graw Frederik, Zimmermann Kathrin, Swiss HIV Cohort Study
Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10
Babouee Flury B, Frei R, Battegay M, Führer U, Garzoni C, Betsch B, Droz S, Ciardo D, Dubuis O, Widmer A, Goldenberger D. Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. Euro Surveill 2011; 16
Mar 17, 2011Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10
Mar 17, 2011Euro Surveill 2011; 16
Babouee Flury Baharak, Frei R, Battegay M, Führer U, Garzoni C, Betsch B Y, Droz S, Ciardo D, Dubuis O, Widmer A F, Goldenberger D
[Vaccination against pneumococci and influenza. How good is the evidence?]
Babouee Flury B, Widmer A, Battegay M. [Vaccination against pneumococci and influenza. How good is the evidence?]. Internist (Berl) 2011; 52:265-76.
Mar 1, 2011[Vaccination against pneumococci and influenza. How good is the evidence?]
Mar 1, 2011Internist (Berl) 2011; 52:265-76
Babouee Flury Baharak, Widmer A F, Battegay M
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
Kaufmann G, Battegay M, Hirschel B, Bernasconi E, Vernazza P, Giulieri S, Furrer H, Weber R, Elzi L, Swiss HIV Cohort Study. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS 2011; 25:441-51.
Feb 20, 2011Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
Feb 20, 2011AIDS 2011; 25:441-51
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Giulieri Stefano, Furrer Hansjakob, Weber Rainer, Elzi Luigia, Swiss HIV Cohort Study
Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus
Babouee Flury B, Frei R, Schultheiss E, Widmer A, Goldenberger D. Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2011; 49:1549-55.
Feb 9, 2011Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus
Feb 9, 2011J Clin Microbiol 2011; 49:1549-55
Babouee Flury Baharak, Frei R, Schultheiss E, Widmer A F, Goldenberger D
Genital shedding of HIV after scheduled treatment interruption
Ananworanich J, Hirschel B, Ruxrungtham K, Cooper D, Jupimai T, Ubolyam S, Mahanontharit A, Chotnopparatpattara P, Chaithongwongwatthana S, Mangclaviraj S, Vernazza P, Kerr S, and the Staccato HIV-NAT Study Group. Genital shedding of HIV after scheduled treatment interruption. Int J STD AIDS 2011; 22:61-6.
Feb 1, 2011Genital shedding of HIV after scheduled treatment interruption
Feb 1, 2011Int J STD AIDS 2011; 22:61-6
Ananworanich J, Hirschel B, Ruxrungtham K, Cooper D A, Jupimai T, Ubolyam S, Mahanontharit A, Chotnopparatpattara P, Chaithongwongwatthana S, Mangclaviraj S, Vernazza Pietro, Kerr S J, and the Staccato HIV-NAT Study Group
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Fehr J, Hirschel B, Vernazza P, Martinetti G, Bernasconi E, Günthard H, Battegay M, Bucher H, Klimkait T, Fux C, Cavassini M, Glass T, Louvel S, Hamy F, Hirsch H, von Wyl V, Böni J, Yerly S, Bürgisser P, Hiv Cohort Study A. Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. J Transl Med 2011; 9:14.
Jan 21, 2011Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Jan 21, 2011J Transl Med 2011; 9:14
Fehr Jan, Hirschel Bernard, Vernazza Pietro, Martinetti Gladys, Bernasconi Enos, Günthard Huldrych F, Battegay Manuel, Bucher Heiner C, Klimkait Thomas, Fux Christoph A, Cavassini Matthias, Glass Tracy R, Louvel Severine, Hamy Francois, Hirsch Hans H, von Wyl Viktor, Böni Jürg, Yerly Sabine, Bürgisser Philippe, Hiv Cohort Study And The Swiss